It is a great pleasure to introduce the recipients of the EFNS Fellowship 2012 (in alphabetical order):
Scientific Fellowship:
Olena Fartushna from Ukraine was selected for her project: cerebral ischaemia measured using MRI spectroscopy (cerebral ischaemia study) which she will… Continue Reading
Get a glimpse of the key highlights, insights, and standout moments from EAN 2025 in Helsinki, all captured in our Congress Review eBook.
Latest Posts
-
-
The EFNS Administration has again been audited on March 21, 2012
-
Norwegian Neuroscience Prize 2011 The Norwegian Pfizer Neuroscience prize for 2011 was awarded to Kjell Arne Arntzen for his oral presentation: “Carotid plaque progression predicts lower cognitive test results in a stroke-free population. The Tromsø Study”. The presentation was given… Continue Reading
-
Top 10 Articles
Top Article: Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial
March 1, 2012Abstract: Background: Diabetic neuropathy is a common complication in diabetes, with patients typically experiencing diverse sensory symptoms including dysesthesias in the feet and usually accompanied by sleep disturbance. There is still no comprehensive understanding of the underlying biologic processes responsible… Continue Reading -
Pietro Cortelli is Professor of Neurology in Bologna, Italy and President of the European Federation of Autonomic Societies
-
Grand Rounds
Case report: Encephalopathy, visual disturbance, and hearing loss in a young female
March 1, 2012by Jan Dörr and Ilka Kleffner We here present a 26-year-old woman who referred herself to our neuroimmunological outpatient department after recurrent episodes of encephalopathy, visual dysfunction, and hearing loss. The presentation of this case was first published in Nature… Continue Reading -
The European Board Examination in Neurology will take place for the 4th time during the EFNS meeting in Stockholm, in 2012. After Milan, Geneva and Lisbon, the UEMS* European Board of Neurology (EBN) examination has become established and is an… Continue Reading
-
Forum
Forum: Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis – From “The Big Idea” to “The Perfect Crime”?
March 1, 2012In April 2011, the EFNS together with ENS and ECTRIMS, have published this important statement. What is the follow-up?
https://www.efns.org/uploads/media/CCSVI_in_MS_ECTRIMS_EFNS_ENS_02.pdf Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis – From “The Big Idea” to “The Perfect Crime”? By Christos Krogias,… Continue Reading -
by Eveline Sipido The European Brain Council (EBC), as a co-ordinating body representing European organisations in neurology, neurosurgery, psychiatry, basic brain research (neuroscience) as well as patient organisations and industry, is ideally positioned to champion and promote brain research in… Continue Reading
-
In early February 2012 we have announced on www.efns.org the publication of a paper by the EFNS and ENS Presidents, Richard Hughes and Zohar Argov. This article is about the establishment of the European Academy of Neurology (EAN), an organisation… Continue Reading
-
In the last six months, the EFNS Scientific Fellowship programme gave me the opportunity to work as visiting scientist in the Laboratory for Molecular Neurology, coordinated by Prof. Dr. Orhan Aktas, at the Department of Neurology of the Heinrich-Heine University, Düsseldorf, Germany, chaired by Prof. Dr. Hans-Peter Hartung.
-
All e-learning activities are free-of-charge for EFNS members, who are registered to www.efns.org! Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology Every month one article is chosen for online learning.
The following… Continue Reading -
Don’t miss the opportunity to present your work to more than 5000 colleagues… 16th EFNS Congress, Stockholm, Sweden, 08-11 September 2012 Abstract submission deadline: March 15, 2012 Please submit your abstract via the congress website http://efns2012.efns.org/ Bursary The EFNS offers… Continue Reading
-
In 2011, for the first time in its 55 year history, the World Federation of Neurology invited project proposals from its membership for specific educational or applied research projects in neurology and the applied neurosciences as part of its activities… Continue Reading
-
Top 10 Articles
Top Article: A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
February 1, 2012Abstract Background: Bapineuzumab, a humanized anti-amyloid-beta (A) monoclonal antibody for the potential treatment of Alzheimer disease (AD), was evaluated in a multiple ascending dose, safety, and efficacy study in mild to moderate AD.
Methods: The study enrolled 234 patients, randomly… Continue Reading